osteoporosis
Dysfunction of the enzyme aromatase (CYP19) is associated with endocrine pathologies such as osteoporosis, impaired fertility and development of hormone-dependent cancers.
Dysfunction of the enzyme aromatase (<span class="gene" id="20723554-1-37-42">CYP19</span>) is associated with endocrine pathologies such as <span class="disease" id="20723554-1-93-105">osteoporosis</span>, impaired fertility and development of hormone-dependent cancers.